Home/Filings/4/0001209191-19-019526
4//SEC Filing

Koh Bong Y 4

Accession 0001209191-19-019526

CIK 0001600132other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 5:51 PM ET

Size

20.5 KB

Accession

0001209191-19-019526

Insider Transaction Report

Form 4
Period: 2019-01-23
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Koh Bong Y
10% Owner
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Transactions
  • Purchase

    Common Stock

    2019-01-23$0.70/sh+142,857$100,0007,529,020 total(indirect: By funds)
Footnotes (3)
  • [F1]This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons.
  • [F2]Consists of (i) 129,871 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 12,986 shares purchased by VHCP Co-Investment Holdings III, LLC.
  • [F3]Venrock Management IV, LLC ("VM4") is the general partner of Venrock Associates IV, LP. Venrock Partners Management, LLC ("VPM") is the general partner of Venrock Partners, LP. VEF Management IV, LLC ("VEFM") is the general partner of Venrock Entrepreneurs Fund IV, LP. VHCP Management II, LLC ("VHCPM2") is the general partner of Venrock Healthcare Capital Partners II, LP and the manager of VHCP Co- Investment Holdings II, LLC. VHCP Management III, LLC ("VHCPM3") is the general partner of Venrock Healthcare Capital Partners III, LP and the manager of VHCP Co-Investment Holdings III, LLC. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3. Each of VM4, VPM, VEFM, VHCPM2, VHCPM3, Bong Koh and Nimish Shah (together, the "Managers") may be deemed to beneficially own these shares. Each of the Managers expressly disclaims beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001615979

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:51 PM ET
Size
20.5 KB